�ݺ�ߣshows by User: 9326389898

�ݺ�ߣshows by User: 9326389898 / http://www.slideshare.net/images/logo.gif �ݺ�ߣshows by User: 9326389898 / Wed, 17 Jul 2024 08:54:50 GMT �ݺ�ߣShare feed for �ݺ�ߣshows by User: 9326389898 (Event) ImmunoBio Series | 14th - 15th October 2024 | Freiburg, Germany /slideshow/event-immunobio-series-14th-15th-october-2024-freiburg-germany/270292774 immunobioseries-240717085451-f4430dab
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany. Register Now @ https://events.marketsandmarkets.com/immunobio-series/register ]]>
Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany. Register Now @ https://events.marketsandmarkets.com/immunobio-series/register ]]> Wed, 17 Jul 2024 08:54:50 GMT /slideshow/event-immunobio-series-14th-15th-october-2024-freiburg-germany/270292774 9326389898@slideshare.net(9326389898) (Event) ImmunoBio Series | 14th - 15th October 2024 | Freiburg, Germany 9326389898 Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany. Register Now @ https://events.marketsandmarkets.com/immunobio-series/register <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/immunobioseries-240717085451-f4430dab-thumbnail.jpg?width=120&height=120&fit=bounds" /> Introducing the 2nd Annual MarketsandMarkets ImmunoBio Series, a groundbreaking event uniting the realms of Biomarker and Immuno-Oncology, set to unfold on 14th - 15th October 2024 in Freiburg, Germany. Register Now @ https://events.marketsandmarkets.com/immunobio-series/register

(Event) ImmunoBio Series | 14th - 15th October 2024 | Freiburg, Germany from 9326389898

]]> 23 0 https://cdn.slidesharecdn.com/ss_thumbnails/immunobioseries-240717085451-f4430dab-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 (Conference) Orphan Drugs and Rare Diseases – US Edition /slideshow/conference-orphan-drugs-and-rare-diseases-us-edition/269785759 us-orphandrugsandrarediseasesconference-240620123347-fb9652b1
Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development. The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare to ultra–rare diseases. Register Now @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/register Conference Speakers- 1. Joslyn Arnon Crowe- Executive Director, National Niemann-Pick Disease Foundation 2. Donna (McKenna) Sullivan- Director of Patient Advocacy, Pathways To Trust 3. Zia Choudhry- Senior Medical Director Rare Autoantibody Diseases – Immunology, Johnson & Johnson 4. Adrian Kielhorn- Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc 5. Karlie Sharma- Program Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH/NCATS) ……………. More Become a speaker @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/speaker-enquiry Key Sessions- • Overview and Regulatory Updates: Current Landscape and Regulatory Developments in US Market. • Emerging Therapies for RDs: Recent breakthroughs in CRISPR-Cas9 technology, Cell & Gene Therapies, mRNA therapies & Precision Treatments. • Rare Disease and Genetics: Rare Genetic Disease Mechanisms and Therapeutic Targets. • Patient Advocacy, Engagement & Collaboration: Critical Role of Patient Advocacy and Global Collaboration in Research and Development. • Global Perspectives and Market Access: Global market dynamics and market access strategies, sustainable models & roadblocks for orphan drugs. • ……more Become a Sponsor @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ADDRESS: Magarpatta City, Hadapsar, Pune, India – 411013]]>
Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development. The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare to ultra–rare diseases. Register Now @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/register Conference Speakers- 1. Joslyn Arnon Crowe- Executive Director, National Niemann-Pick Disease Foundation 2. Donna (McKenna) Sullivan- Director of Patient Advocacy, Pathways To Trust 3. Zia Choudhry- Senior Medical Director Rare Autoantibody Diseases – Immunology, Johnson & Johnson 4. Adrian Kielhorn- Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc 5. Karlie Sharma- Program Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH/NCATS) ……………. More Become a speaker @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/speaker-enquiry Key Sessions- • Overview and Regulatory Updates: Current Landscape and Regulatory Developments in US Market. • Emerging Therapies for RDs: Recent breakthroughs in CRISPR-Cas9 technology, Cell & Gene Therapies, mRNA therapies & Precision Treatments. • Rare Disease and Genetics: Rare Genetic Disease Mechanisms and Therapeutic Targets. • Patient Advocacy, Engagement & Collaboration: Critical Role of Patient Advocacy and Global Collaboration in Research and Development. • Global Perspectives and Market Access: Global market dynamics and market access strategies, sustainable models & roadblocks for orphan drugs. • ……more Become a Sponsor @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ADDRESS: Magarpatta City, Hadapsar, Pune, India – 411013]]> Thu, 20 Jun 2024 12:33:47 GMT /slideshow/conference-orphan-drugs-and-rare-diseases-us-edition/269785759 9326389898@slideshare.net(9326389898) (Conference) Orphan Drugs and Rare Diseases – US Edition 9326389898 Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development. The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare to ultra–rare diseases. Register Now @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/register Conference Speakers- 1. Joslyn Arnon Crowe- Executive Director, National Niemann-Pick Disease Foundation 2. Donna (McKenna) Sullivan- Director of Patient Advocacy, Pathways To Trust 3. Zia Choudhry- Senior Medical Director Rare Autoantibody Diseases – Immunology, Johnson & Johnson 4. Adrian Kielhorn- Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc 5. Karlie Sharma- Program Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH/NCATS) ……………. More Become a speaker @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/speaker-enquiry Key Sessions- • Overview and Regulatory Updates: Current Landscape and Regulatory Developments in US Market. • Emerging Therapies for RDs: Recent breakthroughs in CRISPR-Cas9 technology, Cell & Gene Therapies, mRNA therapies & Precision Treatments. • Rare Disease and Genetics: Rare Genetic Disease Mechanisms and Therapeutic Targets. • Patient Advocacy, Engagement & Collaboration: Critical Role of Patient Advocacy and Global Collaboration in Research and Development. • Global Perspectives and Market Access: Global market dynamics and market access strategies, sustainable models & roadblocks for orphan drugs. • ……more Become a Sponsor @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ADDRESS: Magarpatta City, Hadapsar, Pune, India – 411013 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/us-orphandrugsandrarediseasesconference-240620123347-fb9652b1-thumbnail.jpg?width=120&height=120&fit=bounds" /> Join us at our MarketsandMarkets Orphan Drugs and Rare Diseases Conference in Boston, USA for a groundbreaking exploration of the recent advances in developing life-saving therapies, technologies in diagnosing, and strategies to enhance orphan drug development. The conference will focus on the wide scope of orphan drug developments, critical issues of elevated pricing, reimbursement & access to patients, and strategies to enhance access to novel diagnostics and effective therapies for rare to ultra–rare diseases. Register Now @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/register Conference Speakers- 1. Joslyn Arnon Crowe- Executive Director, National Niemann-Pick Disease Foundation 2. Donna (McKenna) Sullivan- Director of Patient Advocacy, Pathways To Trust 3. Zia Choudhry- Senior Medical Director Rare Autoantibody Diseases – Immunology, Johnson & Johnson 4. Adrian Kielhorn- Senior Director, Global HEOR Neurology, Alexion Pharmaceuticals, Inc 5. Karlie Sharma- Program Director, National Center for Advancing Translational Sciences, National Institutes of Health (NIH/NCATS) ……………. More Become a speaker @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/speaker-enquiry Key Sessions- • Overview and Regulatory Updates: Current Landscape and Regulatory Developments in US Market. • Emerging Therapies for RDs: Recent breakthroughs in CRISPR-Cas9 technology, Cell & Gene Therapies, mRNA therapies & Precision Treatments. • Rare Disease and Genetics: Rare Genetic Disease Mechanisms and Therapeutic Targets. • Patient Advocacy, Engagement & Collaboration: Critical Role of Patient Advocacy and Global Collaboration in Research and Development. • Global Perspectives and Market Access: Global market dynamics and market access strategies, sustainable models & roadblocks for orphan drugs. • ……more Become a Sponsor @ https://events.marketsandmarkets.com/orphan-drugs-and-rare-diseases-conference-us-edition/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ADDRESS: Magarpatta City, Hadapsar, Pune, India – 411013

(Conference) Orphan Drugs and Rare Diseases – US Edition from 9326389898

]]> 10 0 https://cdn.slidesharecdn.com/ss_thumbnails/us-orphandrugsandrarediseasesconference-240620123347-fb9652b1-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Probiotics Conference | Speakers- Nigel Denby, Zoë-Marie Ellis and more (24th - 25th October 2024) /slideshow/probiotics-conference-speakers-nigel-denby-zoe-marie-ellis-and-more-24th-25th-october-2024/269682720 probioticsppt-240614095854-fc1404e8
The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and the crucial link between microbiome science and probiotics. Join us for a transformative experience that is shaping the future of healthcare. Register Now @ https://events.marketsandmarkets.com/probiotics-conference/register Conference Speakers- 1. Zoë-Marie Ellis- Head of Nutrition & Science Communication, Danone | Registered Nutritionist 2. Nigel Denby- Founder,Harley St at Home: Menopause 3. Linia Patel- Woman's Health Dietitian, Performance Nutritionist & Public Health Researcher 4. Lucy Jones- Nutritionist,The Well Retreat 5. Alana Macfarlane Kempner- Founder and CEO,The Gut Stuff …………….More Become a Speaker @ https://events.marketsandmarkets.com/probiotics-conference/speaker-enquiry Key Sessions- • Exploring the Function of the Gut Microbiome and Modulation of Immune Cells • Role of human skin microbiome in precision health • Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy • Oral-Systemic Microbiome Connection and its Modulation • Modulating the Vaginal Microbiome for Women’s Health and Fertility • Mechanisms of Oncobiotic LBP candidate in Enhancing Cancer Immunotherapy • Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer • Microbiome’s role in Cancer • Understanding Microbiome Ecology for Microbiome Modulation • Innovation with Next-Gen Probiotics: • Improving Skin Health with pre-, pro-, and postbiotics • Gut Lung Axis Become a Sponsor @ https://events.marketsandmarkets.com/probiotics-conference/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ]]>
The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and the crucial link between microbiome science and probiotics. Join us for a transformative experience that is shaping the future of healthcare. Register Now @ https://events.marketsandmarkets.com/probiotics-conference/register Conference Speakers- 1. Zoë-Marie Ellis- Head of Nutrition & Science Communication, Danone | Registered Nutritionist 2. Nigel Denby- Founder,Harley St at Home: Menopause 3. Linia Patel- Woman's Health Dietitian, Performance Nutritionist & Public Health Researcher 4. Lucy Jones- Nutritionist,The Well Retreat 5. Alana Macfarlane Kempner- Founder and CEO,The Gut Stuff …………….More Become a Speaker @ https://events.marketsandmarkets.com/probiotics-conference/speaker-enquiry Key Sessions- • Exploring the Function of the Gut Microbiome and Modulation of Immune Cells • Role of human skin microbiome in precision health • Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy • Oral-Systemic Microbiome Connection and its Modulation • Modulating the Vaginal Microbiome for Women’s Health and Fertility • Mechanisms of Oncobiotic LBP candidate in Enhancing Cancer Immunotherapy • Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer • Microbiome’s role in Cancer • Understanding Microbiome Ecology for Microbiome Modulation • Innovation with Next-Gen Probiotics: • Improving Skin Health with pre-, pro-, and postbiotics • Gut Lung Axis Become a Sponsor @ https://events.marketsandmarkets.com/probiotics-conference/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. ]]> Fri, 14 Jun 2024 09:58:54 GMT /slideshow/probiotics-conference-speakers-nigel-denby-zoe-marie-ellis-and-more-24th-25th-october-2024/269682720 9326389898@slideshare.net(9326389898) Probiotics Conference | Speakers- Nigel Denby, Zoë-Marie Ellis and more (24th - 25th October 2024) 9326389898 The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and the crucial link between microbiome science and probiotics. Join us for a transformative experience that is shaping the future of healthcare. Register Now @ https://events.marketsandmarkets.com/probiotics-conference/register Conference Speakers- 1. Zoë-Marie Ellis- Head of Nutrition & Science Communication, Danone | Registered Nutritionist 2. Nigel Denby- Founder,Harley St at Home: Menopause 3. Linia Patel- Woman's Health Dietitian, Performance Nutritionist & Public Health Researcher 4. Lucy Jones- Nutritionist,The Well Retreat 5. Alana Macfarlane Kempner- Founder and CEO,The Gut Stuff …………….More Become a Speaker @ https://events.marketsandmarkets.com/probiotics-conference/speaker-enquiry Key Sessions- • Exploring the Function of the Gut Microbiome and Modulation of Immune Cells • Role of human skin microbiome in precision health • Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy • Oral-Systemic Microbiome Connection and its Modulation • Modulating the Vaginal Microbiome for Women’s Health and Fertility • Mechanisms of Oncobiotic LBP candidate in Enhancing Cancer Immunotherapy • Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer • Microbiome’s role in Cancer • Understanding Microbiome Ecology for Microbiome Modulation • Innovation with Next-Gen Probiotics: • Improving Skin Health with pre-, pro-, and postbiotics • Gut Lung Axis Become a Sponsor @ https://events.marketsandmarkets.com/probiotics-conference/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/probioticsppt-240614095854-fc1404e8-thumbnail.jpg?width=120&height=120&fit=bounds" /> The MarketsandMarkets Probiotics Conference invites you to explore the cutting edge of healthcare on October 24th-25th in London, UK. Delve into the complexities of the human microbiome's influence on health and the environment. Discover the latest breakthroughs in microbiome therapies and probiotics, all while tackling challenges such as limited research and regulatory intricacies. Engage with industry experts across various sectors to gain valuable insights into microbial innovation, regulatory pathways, and the crucial link between microbiome science and probiotics. Join us for a transformative experience that is shaping the future of healthcare. Register Now @ https://events.marketsandmarkets.com/probiotics-conference/register Conference Speakers- 1. Zoë-Marie Ellis- Head of Nutrition & Science Communication, Danone | Registered Nutritionist 2. Nigel Denby- Founder,Harley St at Home: Menopause 3. Linia Patel- Woman's Health Dietitian, Performance Nutritionist & Public Health Researcher 4. Lucy Jones- Nutritionist,The Well Retreat 5. Alana Macfarlane Kempner- Founder and CEO,The Gut Stuff …………….More Become a Speaker @ https://events.marketsandmarkets.com/probiotics-conference/speaker-enquiry Key Sessions- • Exploring the Function of the Gut Microbiome and Modulation of Immune Cells • Role of human skin microbiome in precision health • Modulating the GI Microbiome with Live Biotherapeutic Product to Enhance Efficacy of Cancer Immunotherapy • Oral-Systemic Microbiome Connection and its Modulation • Modulating the Vaginal Microbiome for Women’s Health and Fertility • Mechanisms of Oncobiotic LBP candidate in Enhancing Cancer Immunotherapy • Treating Clostridioides difficile: Microbiota-based Live Biotherapeutic Products to Provide the Answer • Microbiome’s role in Cancer • Understanding Microbiome Ecology for Microbiome Modulation • Innovation with Next-Gen Probiotics: • Improving Skin Health with pre-, pro-, and postbiotics • Gut Lung Axis Become a Sponsor @ https://events.marketsandmarkets.com/probiotics-conference/become-sponsor About Us- MarketsandMarkets Conferences, a leading international event organizer since 2014, takes pride in organizing over 200 conferences globally. With our extensive experience and rich legacy, we bring together experts from around the world to drive knowledge sharing and innovation in the healthcare and lifesciences sectors.

Probiotics Conference | Speakers- Nigel Denby, Zo谷-Marie Ellis and more (24th - 25th October 2024) from 9326389898

]]> 33 0 https://cdn.slidesharecdn.com/ss_thumbnails/probioticsppt-240614095854-fc1404e8-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Real-World Evidence and Market Acces.pptx /slideshow/real-world-evidence-and-market-acces-pptx/269562149 real-worldevidenceandmarketacces-240607161116-0b6f6498
Join us at the MarketsandMarkets 2nd Annual Real-World Evidence and Market Access Conference, October 2024, Freiburg im Breisgau, Germany edition to be at the forefront of driving transformative change in healthcare. This gathering serves a platform where industry leaders, healthcare professionals, and policymakers converge to explore the latest trends, challenges, and innovations shaping the dynamic landscape of evidence-based healthcare and market access strategies. Through engaging keynotes, interactive panel discussions, and networking opportunities, this event aims to foster collaboration, share best practices, and catalyze advancements that drive improved patient outcomes and successful market access across the European healthcare ecosystem. Register Now @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/register Conference Speakers- • Helene Vioix- Director Global Evidence & Value Development Oncology, Merck KGaA • Inha Kim- Vice President, Head of Global Strategy and Communication, Medical Affairs, Lundbeck • Vandana Ayyar Gupta- Scientific Adviser, Data & Analytics, National Institute for Health, and Care Excellence • Iroda Jurabekova- Global Pricing and Market Access Lead, Boehringer Ingelheim • Nivedita Valentine- Global Associate Vice President, Product Innovation, Pharmanovia …..more Become a Speaker @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/speaker-enquiry Key Sessions- • Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies. • Ensuring the reliability, validity, and relevance of RWE in the context of market access. • Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes. • Strategies for pricing and reimbursement that align with evidence-based market access approaches. • The impact of patient-reported outcomes on demonstrating product value and effectiveness. • The role of health economics in demonstrating the economic value of healthcare interventions. ]]>
Join us at the MarketsandMarkets 2nd Annual Real-World Evidence and Market Access Conference, October 2024, Freiburg im Breisgau, Germany edition to be at the forefront of driving transformative change in healthcare. This gathering serves a platform where industry leaders, healthcare professionals, and policymakers converge to explore the latest trends, challenges, and innovations shaping the dynamic landscape of evidence-based healthcare and market access strategies. Through engaging keynotes, interactive panel discussions, and networking opportunities, this event aims to foster collaboration, share best practices, and catalyze advancements that drive improved patient outcomes and successful market access across the European healthcare ecosystem. Register Now @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/register Conference Speakers- • Helene Vioix- Director Global Evidence & Value Development Oncology, Merck KGaA • Inha Kim- Vice President, Head of Global Strategy and Communication, Medical Affairs, Lundbeck • Vandana Ayyar Gupta- Scientific Adviser, Data & Analytics, National Institute for Health, and Care Excellence • Iroda Jurabekova- Global Pricing and Market Access Lead, Boehringer Ingelheim • Nivedita Valentine- Global Associate Vice President, Product Innovation, Pharmanovia …..more Become a Speaker @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/speaker-enquiry Key Sessions- • Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies. • Ensuring the reliability, validity, and relevance of RWE in the context of market access. • Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes. • Strategies for pricing and reimbursement that align with evidence-based market access approaches. • The impact of patient-reported outcomes on demonstrating product value and effectiveness. • The role of health economics in demonstrating the economic value of healthcare interventions. ]]> Fri, 07 Jun 2024 16:11:16 GMT /slideshow/real-world-evidence-and-market-acces-pptx/269562149 9326389898@slideshare.net(9326389898) Real-World Evidence and Market Acces.pptx 9326389898 Join us at the MarketsandMarkets 2nd Annual Real-World Evidence and Market Access Conference, October 2024, Freiburg im Breisgau, Germany edition to be at the forefront of driving transformative change in healthcare. This gathering serves a platform where industry leaders, healthcare professionals, and policymakers converge to explore the latest trends, challenges, and innovations shaping the dynamic landscape of evidence-based healthcare and market access strategies. Through engaging keynotes, interactive panel discussions, and networking opportunities, this event aims to foster collaboration, share best practices, and catalyze advancements that drive improved patient outcomes and successful market access across the European healthcare ecosystem. Register Now @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/register Conference Speakers- • Helene Vioix- Director Global Evidence & Value Development Oncology, Merck KGaA • Inha Kim- Vice President, Head of Global Strategy and Communication, Medical Affairs, Lundbeck • Vandana Ayyar Gupta- Scientific Adviser, Data & Analytics, National Institute for Health, and Care Excellence • Iroda Jurabekova- Global Pricing and Market Access Lead, Boehringer Ingelheim • Nivedita Valentine- Global Associate Vice President, Product Innovation, Pharmanovia …..more Become a Speaker @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/speaker-enquiry Key Sessions- • Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies. • Ensuring the reliability, validity, and relevance of RWE in the context of market access. • Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes. • Strategies for pricing and reimbursement that align with evidence-based market access approaches. • The impact of patient-reported outcomes on demonstrating product value and effectiveness. • The role of health economics in demonstrating the economic value of healthcare interventions. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/real-worldevidenceandmarketacces-240607161116-0b6f6498-thumbnail.jpg?width=120&height=120&fit=bounds" /> Join us at the MarketsandMarkets 2nd Annual Real-World Evidence and Market Access Conference, October 2024, Freiburg im Breisgau, Germany edition to be at the forefront of driving transformative change in healthcare. This gathering serves a platform where industry leaders, healthcare professionals, and policymakers converge to explore the latest trends, challenges, and innovations shaping the dynamic landscape of evidence-based healthcare and market access strategies. Through engaging keynotes, interactive panel discussions, and networking opportunities, this event aims to foster collaboration, share best practices, and catalyze advancements that drive improved patient outcomes and successful market access across the European healthcare ecosystem. Register Now @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/register Conference Speakers- • Helene Vioix- Director Global Evidence & Value Development Oncology, Merck KGaA • Inha Kim- Vice President, Head of Global Strategy and Communication, Medical Affairs, Lundbeck • Vandana Ayyar Gupta- Scientific Adviser, Data & Analytics, National Institute for Health, and Care Excellence • Iroda Jurabekova- Global Pricing and Market Access Lead, Boehringer Ingelheim • Nivedita Valentine- Global Associate Vice President, Product Innovation, Pharmanovia …..more Become a Speaker @ https://events.marketsandmarkets.com/2nd-annual-real-world-evidence-and-market-access-conference/speaker-enquiry Key Sessions- • Updates on European regulatory frameworks governing real-world evidence (RWE) and their impact on market access strategies. • Ensuring the reliability, validity, and relevance of RWE in the context of market access. • Effective collaboration strategies between industry stakeholders and payers to enhance market access outcomes. • Strategies for pricing and reimbursement that align with evidence-based market access approaches. • The impact of patient-reported outcomes on demonstrating product value and effectiveness. • The role of health economics in demonstrating the economic value of healthcare interventions.

Real-World Evidence and Market Acces.pptx from 9326389898

]]> 9 0 https://cdn.slidesharecdn.com/ss_thumbnails/real-worldevidenceandmarketacces-240607161116-0b6f6498-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance /slideshow/medical-device-diagnostics-regulatory-compliance-post-market-surveillance-and-vigilance/269562108 medtech-240607160853-3b6cff8c
In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Register Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/register Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Conference Speakers- • Federica Malvaso- Post Market Surveillance Lead, Lima Corporate • Harish Chengalvala- RA Professional Environmental Compliance and Regulatory Intelligence, Thermo Fisher Scientific • Marco Heim- Senior Manager Post Market Analytics | Global Patient Health & Regulatory Compliance,, KARL STORZ • Carmen Martin- CEO & Founder | Principal consultant, CMG MedDev | MD, IVD, MDSW • Heidi Naderi- Principal Regulatory Consultant, Board-Level Strategic Advisor,, External Partner, Lecturer, Compliant Medical Devices Ltd, EU Notified Body, EU and Saudi Medical Device Law. ………..more Become a Speaker @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/speaker-enquiry ]]>
In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Register Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/register Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Conference Speakers- • Federica Malvaso- Post Market Surveillance Lead, Lima Corporate • Harish Chengalvala- RA Professional Environmental Compliance and Regulatory Intelligence, Thermo Fisher Scientific • Marco Heim- Senior Manager Post Market Analytics | Global Patient Health & Regulatory Compliance,, KARL STORZ • Carmen Martin- CEO & Founder | Principal consultant, CMG MedDev | MD, IVD, MDSW • Heidi Naderi- Principal Regulatory Consultant, Board-Level Strategic Advisor,, External Partner, Lecturer, Compliant Medical Devices Ltd, EU Notified Body, EU and Saudi Medical Device Law. ………..more Become a Speaker @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/speaker-enquiry ]]> Fri, 07 Jun 2024 16:08:53 GMT /slideshow/medical-device-diagnostics-regulatory-compliance-post-market-surveillance-and-vigilance/269562108 9326389898@slideshare.net(9326389898) Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance 9326389898 In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Register Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/register Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Conference Speakers- • Federica Malvaso- Post Market Surveillance Lead, Lima Corporate • Harish Chengalvala- RA Professional Environmental Compliance and Regulatory Intelligence, Thermo Fisher Scientific • Marco Heim- Senior Manager Post Market Analytics | Global Patient Health & Regulatory Compliance,, KARL STORZ • Carmen Martin- CEO & Founder | Principal consultant, CMG MedDev | MD, IVD, MDSW • Heidi Naderi- Principal Regulatory Consultant, Board-Level Strategic Advisor,, External Partner, Lecturer, Compliant Medical Devices Ltd, EU Notified Body, EU and Saudi Medical Device Law. ………..more Become a Speaker @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/speaker-enquiry <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/medtech-240607160853-3b6cff8c-thumbnail.jpg?width=120&height=120&fit=bounds" /> In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th and 15th of October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Register Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/register Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Conference Speakers- • Federica Malvaso- Post Market Surveillance Lead, Lima Corporate • Harish Chengalvala- RA Professional Environmental Compliance and Regulatory Intelligence, Thermo Fisher Scientific • Marco Heim- Senior Manager Post Market Analytics | Global Patient Health & Regulatory Compliance,, KARL STORZ • Carmen Martin- CEO & Founder | Principal consultant, CMG MedDev | MD, IVD, MDSW • Heidi Naderi- Principal Regulatory Consultant, Board-Level Strategic Advisor,, External Partner, Lecturer, Compliant Medical Devices Ltd, EU Notified Body, EU and Saudi Medical Device Law. ………..more Become a Speaker @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-regulatory-compliance-post-market-sruveillance-and-vigilance-dusseldorf-germany/speaker-enquiry

Medical Device & Diagnostics Regulatory, Compliance, Post-Market Surveillance and Vigilance from 9326389898

]]> 39 0 https://cdn.slidesharecdn.com/ss_thumbnails/medtech-240607160853-3b6cff8c-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Next-Gen Immuno-Oncology Conference-20th - 21st June 2024 /slideshow/next-gen-immuno-oncology-conference-20th-21st-june-2024/269562043 next-genimmuno-oncologyconference-240607160424-bc9e5a92
Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register ]]>
Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register ]]> Fri, 07 Jun 2024 16:04:24 GMT /slideshow/next-gen-immuno-oncology-conference-20th-21st-june-2024/269562043 9326389898@slideshare.net(9326389898) Next-Gen Immuno-Oncology Conference-20th - 21st June 2024 9326389898 Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/next-genimmuno-oncologyconference-240607160424-bc9e5a92-thumbnail.jpg?width=120&height=120&fit=bounds" /> Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Hilton Boston Logan Airport, One Drive, Boston, MA 02128, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register

Next-Gen Immuno-Oncology Conference-20th - 21st June 2024 from 9326389898

]]> 16 0 https://cdn.slidesharecdn.com/ss_thumbnails/next-genimmuno-oncologyconference-240607160424-bc9e5a92-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 London Orthopaedic Meeting |13th - 14th June 2024 | London, UK /slideshow/london-orthopaedic-meeting-13th-14th-june-2024-london-uk/267211184 londonorthopaedicmeeting-240411115535-a1ec248b
We are pleased to announce the 3rd Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and future prospects in minimally invasive surgery. The focus will be on managing disorders related to Orthopaedics. Register Now @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/register Over the course of two days, attendees will have the opportunity to engage in expert keynote presentations, participate in breakthrough sessions, and observe live case studies. This scientific meeting will not only facilitate knowledge exchange but also enable networking among peers, ensuring participants stay informed about the most recent developments in the world of minimally invasive surgery. Key Session- • Total ankle replacement- ankle networks and local hospital (spoke) role. • Minimally invasive treatment of calcaneal fracture • Postoperative therapy principles and protocols • Assessment and management of SLAC/SNAC/SCAC wrist • Tennis & Golfers Elbow (Lateral & Medial Epicondylitis) • Arthroscopic bone transfer for anterior shoulder instability • Rehabilitation of shoulder instability • Management of Shoulder instability including non operative approaches • Management of elbow instability and fractures around the elbow • Assessment and management of hand and wrist pain • Common hand therapy techniques Who Should Attend- • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Become a Sponsor @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/become-sponsor]]>
We are pleased to announce the 3rd Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and future prospects in minimally invasive surgery. The focus will be on managing disorders related to Orthopaedics. Register Now @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/register Over the course of two days, attendees will have the opportunity to engage in expert keynote presentations, participate in breakthrough sessions, and observe live case studies. This scientific meeting will not only facilitate knowledge exchange but also enable networking among peers, ensuring participants stay informed about the most recent developments in the world of minimally invasive surgery. Key Session- • Total ankle replacement- ankle networks and local hospital (spoke) role. • Minimally invasive treatment of calcaneal fracture • Postoperative therapy principles and protocols • Assessment and management of SLAC/SNAC/SCAC wrist • Tennis & Golfers Elbow (Lateral & Medial Epicondylitis) • Arthroscopic bone transfer for anterior shoulder instability • Rehabilitation of shoulder instability • Management of Shoulder instability including non operative approaches • Management of elbow instability and fractures around the elbow • Assessment and management of hand and wrist pain • Common hand therapy techniques Who Should Attend- • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Become a Sponsor @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/become-sponsor]]> Thu, 11 Apr 2024 11:55:34 GMT /slideshow/london-orthopaedic-meeting-13th-14th-june-2024-london-uk/267211184 9326389898@slideshare.net(9326389898) London Orthopaedic Meeting |13th - 14th June 2024 | London, UK 9326389898 We are pleased to announce the 3rd Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and future prospects in minimally invasive surgery. The focus will be on managing disorders related to Orthopaedics. Register Now @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/register Over the course of two days, attendees will have the opportunity to engage in expert keynote presentations, participate in breakthrough sessions, and observe live case studies. This scientific meeting will not only facilitate knowledge exchange but also enable networking among peers, ensuring participants stay informed about the most recent developments in the world of minimally invasive surgery. Key Session- • Total ankle replacement- ankle networks and local hospital (spoke) role. • Minimally invasive treatment of calcaneal fracture • Postoperative therapy principles and protocols • Assessment and management of SLAC/SNAC/SCAC wrist • Tennis & Golfers Elbow (Lateral & Medial Epicondylitis) • Arthroscopic bone transfer for anterior shoulder instability • Rehabilitation of shoulder instability • Management of Shoulder instability including non operative approaches • Management of elbow instability and fractures around the elbow • Assessment and management of hand and wrist pain • Common hand therapy techniques Who Should Attend- • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Become a Sponsor @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/become-sponsor <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/londonorthopaedicmeeting-240411115535-a1ec248b-thumbnail.jpg?width=120&height=120&fit=bounds" /> We are pleased to announce the 3rd Annual MarketsandMarkets London Orthopaedic Meeting, scheduled to take place on 13th-14th June 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and future prospects in minimally invasive surgery. The focus will be on managing disorders related to Orthopaedics. Register Now @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/register Over the course of two days, attendees will have the opportunity to engage in expert keynote presentations, participate in breakthrough sessions, and observe live case studies. This scientific meeting will not only facilitate knowledge exchange but also enable networking among peers, ensuring participants stay informed about the most recent developments in the world of minimally invasive surgery. Key Session- • Total ankle replacement- ankle networks and local hospital (spoke) role. • Minimally invasive treatment of calcaneal fracture • Postoperative therapy principles and protocols • Assessment and management of SLAC/SNAC/SCAC wrist • Tennis & Golfers Elbow (Lateral & Medial Epicondylitis) • Arthroscopic bone transfer for anterior shoulder instability • Rehabilitation of shoulder instability • Management of Shoulder instability including non operative approaches • Management of elbow instability and fractures around the elbow • Assessment and management of hand and wrist pain • Common hand therapy techniques Who Should Attend- • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Become a Sponsor @ https://events.marketsandmarkets.com/london-orthopaedic-meeting/become-sponsor

London Orthopaedic Meeting |13th - 14th June 2024 | London, UK from 9326389898

]]> 70 0 https://cdn.slidesharecdn.com/ss_thumbnails/londonorthopaedicmeeting-240411115535-a1ec248b-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Next-Gen Immuno-Oncology Conference-Boston USA /slideshow/nextgen-immunooncology-conferenceboston-usa/267126885 next-genimmuno-oncologyconference-240405122444-ceb2fc0b
Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.]]>
Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.]]> Fri, 05 Apr 2024 12:24:44 GMT /slideshow/nextgen-immunooncology-conferenceboston-usa/267126885 9326389898@slideshare.net(9326389898) Next-Gen Immuno-Oncology Conference-Boston USA 9326389898 Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy. <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/next-genimmuno-oncologyconference-240405122444-ceb2fc0b-thumbnail.jpg?width=120&height=120&fit=bounds" /> Our 7th Annual MarketsandMarkets Next Gen Immuno-Oncology Conference to be held on 20th - 21st June 2024, in Boston, USA would address the challenges and future directions in IO research. The congress aims to bring academicians, researchers and scientists from research institutes pharmaceutical, bio-pharmaceutical and biotechnology companies to discuss the latest updates in the development of ADCs, Bispecific Antibodies, Cellular Therapy and Immune Checkpoint Inhibitors. Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-boston/register This congress would also focus on various combination strategies, pre-clinical and translational immune-oncology developments, updates in cellular and viral therapies, vaccine development and personalized immunotherapy. Keynote presentations, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced and come up with solutions. With more than 20 speakers across the world from pharma, bio-pharma and biotech companies, the congress will discuss the latest updates in the development of ADCs, Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors and Cellular Therapy.

Next-Gen Immuno-Oncology Conference-Boston USA from 9326389898

]]> 20 0 https://cdn.slidesharecdn.com/ss_thumbnails/next-genimmuno-oncologyconference-240405122444-ceb2fc0b-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Minimally Invasive Surgery | 21st - 22nd March 2024 /slideshow/minimally-invasive-surgery-21st-22nd-march-2024/266786210 minimallyinvasivesurgeryconference-240314113630-734ffae7
We are pleased to announce the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, scheduled to take place on March 21st-22nd, 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and prospects in minimally invasive surgery. The focus will be on managing disorders related to urology, gynecology, & orthopedics. Enquire Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/ Key Sessions: Urology- • The Minimally Invasive Penile Implant • Improving Outcomes in Robotic Prostatectomy - The Role of Advanced Imaging Platforms • Next-Gen Lasers in the Management of Urothelial Cancer • Minimally invasive cystectomy approaches in the treatment of bladder cancer • Why is Laparoscopic Pyeloplasty Better than Robotic? • Laparoscopic surgery for Enlarged Prostate in Benign Condition Gynecology- • Taking the Next Steps to Eliminate Cervical Cancer • Insulin Resistance and Metabolic Syndrome in Women’s Health • The Next-Gen Advances in Gynecological Endoscopy • Intraoperative use of Indocyanine Green (ICG) in Gynecological malignancies • Robotic in Complex Benign Gynecology • Staging for Endometrial Cancer • Varicocelectomy improves the sperm capacity to induce optimal embryonic development post-fertilization Become a Speaker @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/speaker-enquiry Why Attend- • Stay Updated: The conference provides a platform to stay up-to-date with the latest advancements, techniques, and technologies in minimally invasive surgery. • Networking Opportunities: The conference offers an excellent opportunity to network, interact, and collaborate with peers, industry leaders, and renowned experts. • Knowledge Exchange: Attendees can benefit from the knowledge and experience of keynote speakers and presenters who share their expertise and insights during presentations, panel discussions, and interactive sessions. You can gain valuable insights, learn new techniques, and discover practical approaches to enhance your skills and expertise in MIS. • Live Case Studies: The conference features live case studies, where you can observe real surgical procedures and learn firsthand from experienced surgeons. Who Should Attend- From hospitals, universities and private clinics associated with urology & gynecology. • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Register Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/register ]]>
We are pleased to announce the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, scheduled to take place on March 21st-22nd, 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and prospects in minimally invasive surgery. The focus will be on managing disorders related to urology, gynecology, & orthopedics. Enquire Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/ Key Sessions: Urology- • The Minimally Invasive Penile Implant • Improving Outcomes in Robotic Prostatectomy - The Role of Advanced Imaging Platforms • Next-Gen Lasers in the Management of Urothelial Cancer • Minimally invasive cystectomy approaches in the treatment of bladder cancer • Why is Laparoscopic Pyeloplasty Better than Robotic? • Laparoscopic surgery for Enlarged Prostate in Benign Condition Gynecology- • Taking the Next Steps to Eliminate Cervical Cancer • Insulin Resistance and Metabolic Syndrome in Women’s Health • The Next-Gen Advances in Gynecological Endoscopy • Intraoperative use of Indocyanine Green (ICG) in Gynecological malignancies • Robotic in Complex Benign Gynecology • Staging for Endometrial Cancer • Varicocelectomy improves the sperm capacity to induce optimal embryonic development post-fertilization Become a Speaker @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/speaker-enquiry Why Attend- • Stay Updated: The conference provides a platform to stay up-to-date with the latest advancements, techniques, and technologies in minimally invasive surgery. • Networking Opportunities: The conference offers an excellent opportunity to network, interact, and collaborate with peers, industry leaders, and renowned experts. • Knowledge Exchange: Attendees can benefit from the knowledge and experience of keynote speakers and presenters who share their expertise and insights during presentations, panel discussions, and interactive sessions. You can gain valuable insights, learn new techniques, and discover practical approaches to enhance your skills and expertise in MIS. • Live Case Studies: The conference features live case studies, where you can observe real surgical procedures and learn firsthand from experienced surgeons. Who Should Attend- From hospitals, universities and private clinics associated with urology & gynecology. • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Register Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/register ]]> Thu, 14 Mar 2024 11:36:30 GMT /slideshow/minimally-invasive-surgery-21st-22nd-march-2024/266786210 9326389898@slideshare.net(9326389898) Minimally Invasive Surgery | 21st - 22nd March 2024 9326389898 We are pleased to announce the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, scheduled to take place on March 21st-22nd, 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and prospects in minimally invasive surgery. The focus will be on managing disorders related to urology, gynecology, & orthopedics. Enquire Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/ Key Sessions: Urology- • The Minimally Invasive Penile Implant • Improving Outcomes in Robotic Prostatectomy - The Role of Advanced Imaging Platforms • Next-Gen Lasers in the Management of Urothelial Cancer • Minimally invasive cystectomy approaches in the treatment of bladder cancer • Why is Laparoscopic Pyeloplasty Better than Robotic? • Laparoscopic surgery for Enlarged Prostate in Benign Condition Gynecology- • Taking the Next Steps to Eliminate Cervical Cancer • Insulin Resistance and Metabolic Syndrome in Women’s Health • The Next-Gen Advances in Gynecological Endoscopy • Intraoperative use of Indocyanine Green (ICG) in Gynecological malignancies • Robotic in Complex Benign Gynecology • Staging for Endometrial Cancer • Varicocelectomy improves the sperm capacity to induce optimal embryonic development post-fertilization Become a Speaker @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/speaker-enquiry Why Attend- • Stay Updated: The conference provides a platform to stay up-to-date with the latest advancements, techniques, and technologies in minimally invasive surgery. • Networking Opportunities: The conference offers an excellent opportunity to network, interact, and collaborate with peers, industry leaders, and renowned experts. • Knowledge Exchange: Attendees can benefit from the knowledge and experience of keynote speakers and presenters who share their expertise and insights during presentations, panel discussions, and interactive sessions. You can gain valuable insights, learn new techniques, and discover practical approaches to enhance your skills and expertise in MIS. • Live Case Studies: The conference features live case studies, where you can observe real surgical procedures and learn firsthand from experienced surgeons. Who Should Attend- From hospitals, universities and private clinics associated with urology & gynecology. • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Register Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/register <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/minimallyinvasivesurgeryconference-240314113630-734ffae7-thumbnail.jpg?width=120&height=120&fit=bounds" /> We are pleased to announce the 3rd Annual MarketsandMarkets Minimally Invasive Surgery Conference, scheduled to take place on March 21st-22nd, 2024, in London, UK. This conference aims to provide a platform for surgeons, physicians, residents, clinical specialty nurses, and other medical professionals to gather and discuss the latest technological advancements, emerging trends, challenges, and prospects in minimally invasive surgery. The focus will be on managing disorders related to urology, gynecology, & orthopedics. Enquire Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/ Key Sessions: Urology- • The Minimally Invasive Penile Implant • Improving Outcomes in Robotic Prostatectomy - The Role of Advanced Imaging Platforms • Next-Gen Lasers in the Management of Urothelial Cancer • Minimally invasive cystectomy approaches in the treatment of bladder cancer • Why is Laparoscopic Pyeloplasty Better than Robotic? • Laparoscopic surgery for Enlarged Prostate in Benign Condition Gynecology- • Taking the Next Steps to Eliminate Cervical Cancer • Insulin Resistance and Metabolic Syndrome in Women’s Health • The Next-Gen Advances in Gynecological Endoscopy • Intraoperative use of Indocyanine Green (ICG) in Gynecological malignancies • Robotic in Complex Benign Gynecology • Staging for Endometrial Cancer • Varicocelectomy improves the sperm capacity to induce optimal embryonic development post-fertilization Become a Speaker @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/speaker-enquiry Why Attend- • Stay Updated: The conference provides a platform to stay up-to-date with the latest advancements, techniques, and technologies in minimally invasive surgery. • Networking Opportunities: The conference offers an excellent opportunity to network, interact, and collaborate with peers, industry leaders, and renowned experts. • Knowledge Exchange: Attendees can benefit from the knowledge and experience of keynote speakers and presenters who share their expertise and insights during presentations, panel discussions, and interactive sessions. You can gain valuable insights, learn new techniques, and discover practical approaches to enhance your skills and expertise in MIS. • Live Case Studies: The conference features live case studies, where you can observe real surgical procedures and learn firsthand from experienced surgeons. Who Should Attend- From hospitals, universities and private clinics associated with urology & gynecology. • Surgeons • Primary care physicians • Professors • Researchers • Residents • Fellows-in-training • Clinical specialty nurses/clinical nurse specialists/endoscopy nurses • Theatre scrubs • Surgical technologists • Biomedical scientists/engineers Register Now @ https://events.marketsandmarkets.com/minimally-invasive-surgery-conference/register

Minimally Invasive Surgery | 21st - 22nd March 2024 from 9326389898

]]> 46 0 https://cdn.slidesharecdn.com/ss_thumbnails/minimallyinvasivesurgeryconference-240314113630-734ffae7-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference|14th - 15th October 2024 /slideshow/european-medical-device-diagnostics-postmarket-surveillance-and-vigilance-conference14th-15th-october-2024/266676379 europeanmedicaldevicediagnosticspost-marketsurveillanceandvigilanceconference-240307125100-80ee2d73
Introduction: In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Enquire Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-post-market-sruveillance-and-vigilance-dusseldorf-germany/ Key Highlights: • Regulatory Compliance and Updates: The conference will kick off with a thorough examination of the latest regulatory frameworks impacting medical devices and diagnostics. Attendees can expect to gain insights into recent updates, compliance requirements, and best practices to navigate the complex regulatory landscape. • Technological Innovations in Surveillance: In an era dominated by technological breakthroughs, the conference will feature sessions dedicated to exploring cutting-edge technologies transforming post-market surveillance. Discussions will cover artificial intelligence, data analytics, and other innovative approaches that contribute to proactive monitoring and rapid response. • Risk Management and Mitigation Strategies: As the medical field faces an array of risks associated with product usage, speakers and panelists will delve into effective risk management strategies. Case studies and real-world examples will be shared to illustrate successful approaches to identifying, assessing, and mitigating risks in the post-market phase. • Global Collaboration for Safer Healthcare: The conference will serve as a nexus for professionals to connect, share experiences, and establish collaborative networks. Attendees will have the opportunity to engage in discussions on fostering global collaboration to address common challenges and promote a safer healthcare environment. • Patient-Centric Approaches: Recognizing the pivotal role of patients in the healthcare journey, the conference will emphasize patient-centric perspectives in post-market surveillance and vigilance. Discussions will center around patient engagement, feedback mechanisms, and the integration of patient experiences into continuous improvement processes. ......more]]>
Introduction: In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Enquire Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-post-market-sruveillance-and-vigilance-dusseldorf-germany/ Key Highlights: • Regulatory Compliance and Updates: The conference will kick off with a thorough examination of the latest regulatory frameworks impacting medical devices and diagnostics. Attendees can expect to gain insights into recent updates, compliance requirements, and best practices to navigate the complex regulatory landscape. • Technological Innovations in Surveillance: In an era dominated by technological breakthroughs, the conference will feature sessions dedicated to exploring cutting-edge technologies transforming post-market surveillance. Discussions will cover artificial intelligence, data analytics, and other innovative approaches that contribute to proactive monitoring and rapid response. • Risk Management and Mitigation Strategies: As the medical field faces an array of risks associated with product usage, speakers and panelists will delve into effective risk management strategies. Case studies and real-world examples will be shared to illustrate successful approaches to identifying, assessing, and mitigating risks in the post-market phase. • Global Collaboration for Safer Healthcare: The conference will serve as a nexus for professionals to connect, share experiences, and establish collaborative networks. Attendees will have the opportunity to engage in discussions on fostering global collaboration to address common challenges and promote a safer healthcare environment. • Patient-Centric Approaches: Recognizing the pivotal role of patients in the healthcare journey, the conference will emphasize patient-centric perspectives in post-market surveillance and vigilance. Discussions will center around patient engagement, feedback mechanisms, and the integration of patient experiences into continuous improvement processes. ......more]]> Thu, 07 Mar 2024 12:51:00 GMT /slideshow/european-medical-device-diagnostics-postmarket-surveillance-and-vigilance-conference14th-15th-october-2024/266676379 9326389898@slideshare.net(9326389898) European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference|14th - 15th October 2024 9326389898 Introduction: In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Enquire Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-post-market-sruveillance-and-vigilance-dusseldorf-germany/ Key Highlights: • Regulatory Compliance and Updates: The conference will kick off with a thorough examination of the latest regulatory frameworks impacting medical devices and diagnostics. Attendees can expect to gain insights into recent updates, compliance requirements, and best practices to navigate the complex regulatory landscape. • Technological Innovations in Surveillance: In an era dominated by technological breakthroughs, the conference will feature sessions dedicated to exploring cutting-edge technologies transforming post-market surveillance. Discussions will cover artificial intelligence, data analytics, and other innovative approaches that contribute to proactive monitoring and rapid response. • Risk Management and Mitigation Strategies: As the medical field faces an array of risks associated with product usage, speakers and panelists will delve into effective risk management strategies. Case studies and real-world examples will be shared to illustrate successful approaches to identifying, assessing, and mitigating risks in the post-market phase. • Global Collaboration for Safer Healthcare: The conference will serve as a nexus for professionals to connect, share experiences, and establish collaborative networks. Attendees will have the opportunity to engage in discussions on fostering global collaboration to address common challenges and promote a safer healthcare environment. • Patient-Centric Approaches: Recognizing the pivotal role of patients in the healthcare journey, the conference will emphasize patient-centric perspectives in post-market surveillance and vigilance. Discussions will center around patient engagement, feedback mechanisms, and the integration of patient experiences into continuous improvement processes. ......more <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/europeanmedicaldevicediagnosticspost-marketsurveillanceandvigilanceconference-240307125100-80ee2d73-thumbnail.jpg?width=120&height=120&fit=bounds" /> Introduction: In the heart of Dusseldorf, Germany, the MarketsandMarkets European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference is set to unfold on the 14th-15th October 2024. This pivotal event gathers professionals, experts, and thought leaders from the healthcare industry, providing a comprehensive platform to explore and navigate the evolving landscape of post-market surveillance and vigilance in medical devices and diagnostics. Conference Overview: As the global healthcare sector continues to witness rapid advancements and innovation, ensuring the safety, efficacy, and regulatory compliance of medical devices and diagnostics becomes increasingly crucial. The upcoming conference stands as a beacon for professionals seeking to deepen their understanding of post-market surveillance and vigilance, exchange insights, and foster collaboration to enhance the overall quality and safety of healthcare practices. Enquire Now @ https://events.marketsandmarkets.com/european-medical-devices-and-diagnostics-post-market-sruveillance-and-vigilance-dusseldorf-germany/ Key Highlights: • Regulatory Compliance and Updates: The conference will kick off with a thorough examination of the latest regulatory frameworks impacting medical devices and diagnostics. Attendees can expect to gain insights into recent updates, compliance requirements, and best practices to navigate the complex regulatory landscape. • Technological Innovations in Surveillance: In an era dominated by technological breakthroughs, the conference will feature sessions dedicated to exploring cutting-edge technologies transforming post-market surveillance. Discussions will cover artificial intelligence, data analytics, and other innovative approaches that contribute to proactive monitoring and rapid response. • Risk Management and Mitigation Strategies: As the medical field faces an array of risks associated with product usage, speakers and panelists will delve into effective risk management strategies. Case studies and real-world examples will be shared to illustrate successful approaches to identifying, assessing, and mitigating risks in the post-market phase. • Global Collaboration for Safer Healthcare: The conference will serve as a nexus for professionals to connect, share experiences, and establish collaborative networks. Attendees will have the opportunity to engage in discussions on fostering global collaboration to address common challenges and promote a safer healthcare environment. • Patient-Centric Approaches: Recognizing the pivotal role of patients in the healthcare journey, the conference will emphasize patient-centric perspectives in post-market surveillance and vigilance. Discussions will center around patient engagement, feedback mechanisms, and the integration of patient experiences into continuous improvement processes. ......more

European Medical Device & Diagnostics Post-Market Surveillance and Vigilance Conference|14th - 15th October 2024 from 9326389898

]]> 54 0 https://cdn.slidesharecdn.com/ss_thumbnails/europeanmedicaldevicediagnosticspost-marketsurveillanceandvigilanceconference-240307125100-80ee2d73-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Next-Gen Immuno-Oncology Conference - MarketsandMarkets /slideshow/nextgen-immunooncology-conference-marketsandmarkets/266443616 8th-next-genimmuno-oncologyconference-240222164622-a212139a
Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment. Enquire Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/ As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology. Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer. Key Highlights: • Updates in development of ADC’s and Bispecific Ab’s • Immune Checkpoint Inhibitors and Combinations • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators) • Biomarkers and Personalized Medicine in IO • CAR-T Cell therapy, TCR Based-Cell Therapy • Tumor microenvironment and Oncolytic Viruses Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/register ]]>
Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment. Enquire Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/ As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology. Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer. Key Highlights: • Updates in development of ADC’s and Bispecific Ab’s • Immune Checkpoint Inhibitors and Combinations • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators) • Biomarkers and Personalized Medicine in IO • CAR-T Cell therapy, TCR Based-Cell Therapy • Tumor microenvironment and Oncolytic Viruses Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/register ]]> Thu, 22 Feb 2024 16:46:22 GMT /slideshow/nextgen-immunooncology-conference-marketsandmarkets/266443616 9326389898@slideshare.net(9326389898) Next-Gen Immuno-Oncology Conference - MarketsandMarkets 9326389898 Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment. Enquire Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/ As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology. Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer. Key Highlights: • Updates in development of ADC’s and Bispecific Ab’s • Immune Checkpoint Inhibitors and Combinations • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators) • Biomarkers and Personalized Medicine in IO • CAR-T Cell therapy, TCR Based-Cell Therapy • Tumor microenvironment and Oncolytic Viruses Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/register <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/8th-next-genimmuno-oncologyconference-240222164622-a212139a-thumbnail.jpg?width=120&height=120&fit=bounds" /> Welcome to the 8th Annual MarketsandMarkets Next-Gen Immuno-Oncology Conference, a premier event dedicated to advancing the field of immuno-oncology. Join us on 07th - 8th March 2024 in London, UK, where leading experts, researchers, and industry professionals will gather to shape the future of cancer treatment. Enquire Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/ As a prominent Immuno-Oncology Conference, this event offers a unique platform to explore the latest advancements, breakthroughs, and innovations in the field. From antibodies and cellular therapies to immune-checkpoint research, our comprehensive program covers a wide range of topics, ensuring a holistic understanding of the dynamic landscape of immuno-oncology. Engage in interactive sessions, insightful panel discussions, and thought-provoking keynote speeches delivered by renowned speakers. Contribute to interactive roundtables, where you can deliberate on key topics that are most relevant to your field. Exchange knowledge, network with peers, and foster collaborations with experts from around the world, as we collectively strive to drive progress and inspire hope in the fight against cancer. Key Highlights: • Updates in development of ADC’s and Bispecific Ab’s • Immune Checkpoint Inhibitors and Combinations • Preclinical and Translational Immuno-Oncology Developments (Preclinical models for Immune checkpoint modulators) • Biomarkers and Personalized Medicine in IO • CAR-T Cell therapy, TCR Based-Cell Therapy • Tumor microenvironment and Oncolytic Viruses Register Now @ https://events.marketsandmarkets.com/immuno-oncology-conference-london/register

Next-Gen Immuno-Oncology Conference - MarketsandMarkets from 9326389898

]]> 20 0 https://cdn.slidesharecdn.com/ss_thumbnails/8th-next-genimmuno-oncologyconference-240222164622-a212139a-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 Infection Control, Sterilization & Decontamination Conference | MarketsandMarkets /slideshow/infection-control-sterilization-decontamination-conference-marketsandmarkets/266419702 infectioncontrolsterilizationdecontaminationconference-240221125542-2afd0d94
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21–22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving and maintaining an infection-free environment in the hospital and outpatient settings, as well as effective and research-based ways to reduce the risks of the outbreak of healthcare-associated infections through microbes and medical equipment because of subpar infection prevention and control methods and contaminated medical devices. Key Highlights: • Antimicrobial stewardship & multidrug- resistant organisms. • Hand hygiene protocols and best practices • Importance of surveillance & green initiatives • Practices for sustainable Waste Management • Surgical site infections – What are they? • Effective Disinfection Practices for Hemodialysis • Sterilization and decontamination of endoscopes • Educating and Training – Key Pillar of IPC • Which is better, Reusable or Disposable? • Automated Cleaning – Role of technology in IC • Manual Cleaning & Effective Documentation • Challenges and Factors affecting in Sterilization of medical devices • Antimicrobial surfaces and their role in infection prevention. • ATP Verses Fluorescent markers – superior representative • How Sustainable is Patient Safety within Decontamination? • Infections in the immunocompromised host & Pediatric Infections • Infection control & prevention in hospital/critical (ICU) & outpatient care Become a Speaker @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/speaker-enquiry Who Should Attend? Surgeons, Doctors, Professors, Researchers, and Faculty from Hospitals and Academic institutions related to: Infection Control Department • Director Infection Prevention and Control • Assistant Director Infection Prevention and Control • Microbiologist • Risk/Governance Manager • Junior Doctor • Lead Nurse Infection Prevention and Control • Senior Lecturer/Lecturer • Matron / Nurse • Infection Prevention and Control Nurse/Practitioner • Consultant Nurses / Specialists Sterile Services Department (SSD) and Decontamination Department • Director/Asst. Director • Head • Manager/ Lead • Deputy Manager/Quality Management Representative • Coordinator • Supervisors • Team Leaders • Technicians / Engineers Endoscopy Unit • Director • Head/ Manager • Nurse Quality department • Quality officer Patient Safety • Patient safety officer • Patient safety practitioner]]>
MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21–22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving and maintaining an infection-free environment in the hospital and outpatient settings, as well as effective and research-based ways to reduce the risks of the outbreak of healthcare-associated infections through microbes and medical equipment because of subpar infection prevention and control methods and contaminated medical devices. Key Highlights: • Antimicrobial stewardship & multidrug- resistant organisms. • Hand hygiene protocols and best practices • Importance of surveillance & green initiatives • Practices for sustainable Waste Management • Surgical site infections – What are they? • Effective Disinfection Practices for Hemodialysis • Sterilization and decontamination of endoscopes • Educating and Training – Key Pillar of IPC • Which is better, Reusable or Disposable? • Automated Cleaning – Role of technology in IC • Manual Cleaning & Effective Documentation • Challenges and Factors affecting in Sterilization of medical devices • Antimicrobial surfaces and their role in infection prevention. • ATP Verses Fluorescent markers – superior representative • How Sustainable is Patient Safety within Decontamination? • Infections in the immunocompromised host & Pediatric Infections • Infection control & prevention in hospital/critical (ICU) & outpatient care Become a Speaker @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/speaker-enquiry Who Should Attend? Surgeons, Doctors, Professors, Researchers, and Faculty from Hospitals and Academic institutions related to: Infection Control Department • Director Infection Prevention and Control • Assistant Director Infection Prevention and Control • Microbiologist • Risk/Governance Manager • Junior Doctor • Lead Nurse Infection Prevention and Control • Senior Lecturer/Lecturer • Matron / Nurse • Infection Prevention and Control Nurse/Practitioner • Consultant Nurses / Specialists Sterile Services Department (SSD) and Decontamination Department • Director/Asst. Director • Head • Manager/ Lead • Deputy Manager/Quality Management Representative • Coordinator • Supervisors • Team Leaders • Technicians / Engineers Endoscopy Unit • Director • Head/ Manager • Nurse Quality department • Quality officer Patient Safety • Patient safety officer • Patient safety practitioner]]> Wed, 21 Feb 2024 12:55:42 GMT /slideshow/infection-control-sterilization-decontamination-conference-marketsandmarkets/266419702 9326389898@slideshare.net(9326389898) Infection Control, Sterilization & Decontamination Conference | MarketsandMarkets 9326389898 MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21–22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving and maintaining an infection-free environment in the hospital and outpatient settings, as well as effective and research-based ways to reduce the risks of the outbreak of healthcare-associated infections through microbes and medical equipment because of subpar infection prevention and control methods and contaminated medical devices. Key Highlights: • Antimicrobial stewardship & multidrug- resistant organisms. • Hand hygiene protocols and best practices • Importance of surveillance & green initiatives • Practices for sustainable Waste Management • Surgical site infections – What are they? • Effective Disinfection Practices for Hemodialysis • Sterilization and decontamination of endoscopes • Educating and Training – Key Pillar of IPC • Which is better, Reusable or Disposable? • Automated Cleaning – Role of technology in IC • Manual Cleaning & Effective Documentation • Challenges and Factors affecting in Sterilization of medical devices • Antimicrobial surfaces and their role in infection prevention. • ATP Verses Fluorescent markers – superior representative • How Sustainable is Patient Safety within Decontamination? • Infections in the immunocompromised host & Pediatric Infections • Infection control & prevention in hospital/critical (ICU) & outpatient care Become a Speaker @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/speaker-enquiry Who Should Attend? Surgeons, Doctors, Professors, Researchers, and Faculty from Hospitals and Academic institutions related to: Infection Control Department • Director Infection Prevention and Control • Assistant Director Infection Prevention and Control • Microbiologist • Risk/Governance Manager • Junior Doctor • Lead Nurse Infection Prevention and Control • Senior Lecturer/Lecturer • Matron / Nurse • Infection Prevention and Control Nurse/Practitioner • Consultant Nurses / Specialists Sterile Services Department (SSD) and Decontamination Department • Director/Asst. Director • Head • Manager/ Lead • Deputy Manager/Quality Management Representative • Coordinator • Supervisors • Team Leaders • Technicians / Engineers Endoscopy Unit • Director • Head/ Manager • Nurse Quality department • Quality officer Patient Safety • Patient safety officer • Patient safety practitioner <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/infectioncontrolsterilizationdecontaminationconference-240221125542-2afd0d94-thumbnail.jpg?width=120&height=120&fit=bounds" /> MarketsandMarkets is pleased to announce its 8th Annual Infection Control, Sterilisation, and Decontamination in Healthcare Conference, which will take place March 21–22, 2024, in London, UK. With the increased risk of infection due to improper sterilisation and decontamination practices, the safety of patients and healthcare workers is of paramount importance nowadays. Enquire Now @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/ This conference aims to bring together all the stakeholders to discuss the obstacles in achieving and maintaining an infection-free environment in the hospital and outpatient settings, as well as effective and research-based ways to reduce the risks of the outbreak of healthcare-associated infections through microbes and medical equipment because of subpar infection prevention and control methods and contaminated medical devices. Key Highlights: • Antimicrobial stewardship & multidrug- resistant organisms. • Hand hygiene protocols and best practices • Importance of surveillance & green initiatives • Practices for sustainable Waste Management • Surgical site infections – What are they? • Effective Disinfection Practices for Hemodialysis • Sterilization and decontamination of endoscopes • Educating and Training – Key Pillar of IPC • Which is better, Reusable or Disposable? • Automated Cleaning – Role of technology in IC • Manual Cleaning & Effective Documentation • Challenges and Factors affecting in Sterilization of medical devices • Antimicrobial surfaces and their role in infection prevention. • ATP Verses Fluorescent markers – superior representative • How Sustainable is Patient Safety within Decontamination? • Infections in the immunocompromised host & Pediatric Infections • Infection control & prevention in hospital/critical (ICU) & outpatient care Become a Speaker @ https://events.marketsandmarkets.com/infection-control-sterilization-and-decontamination-conference/speaker-enquiry Who Should Attend? Surgeons, Doctors, Professors, Researchers, and Faculty from Hospitals and Academic institutions related to: Infection Control Department • Director Infection Prevention and Control • Assistant Director Infection Prevention and Control • Microbiologist • Risk/Governance Manager • Junior Doctor • Lead Nurse Infection Prevention and Control • Senior Lecturer/Lecturer • Matron / Nurse • Infection Prevention and Control Nurse/Practitioner • Consultant Nurses / Specialists Sterile Services Department (SSD) and Decontamination Department • Director/Asst. Director • Head • Manager/ Lead • Deputy Manager/Quality Management Representative • Coordinator • Supervisors • Team Leaders • Technicians / Engineers Endoscopy Unit • Director • Head/ Manager • Nurse Quality department • Quality officer Patient Safety • Patient safety officer • Patient safety practitioner

Infection Control, Sterilization & Decontamination Conference | MarketsandMarkets from 9326389898

]]> 116 0 https://cdn.slidesharecdn.com/ss_thumbnails/infectioncontrolsterilizationdecontaminationconference-240221125542-2afd0d94-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 2024 Next-Gen Microbiome and Probiotics Conference |Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods /slideshow/2024-nextgen-microbiome-and-probiotics-conference-microbiology-microbiome-therapeutics-microbiome-gastroenterology-neonatology-functional-foods/265769261 next-genmicrobiomeandprobioticsconference-240124161537-7e93d39c
The human microbiome is the aggregate of all microbiotas that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Register Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/register Probiotics- Probiotics are live microorganisms promoted with claims that they provide health benefits when consumed, generally by improving or restoring the gut flora. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in your body. Bacteria is usually viewed in a negative light as something that makes you sick. However, you have two kinds of bacteria constantly in and on your body — good bacteria and bad bacteria. Probiotics are made up of good bacteria that helps keep your body healthy and working well. This good bacteria helps you in many ways, including fighting off bad bacteria when you have too much of it, helping you feel better. Key Highlights: • Effective Microbiome Therapeutics in Production • Role of human skin microbiome in precision health • The increasing pro bacterial beauty industry • Business collaborations- Regulations and Investments • Microbiome as a science and its clinical applications- skin, gut & women’s health • Regulatory pathways • Prebiotics, Probiotics and Postbiotics • R&D to commercialization- effectively translating research into commercialization • Rightly educating the consumer Academia- Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of: Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods, Nutritionists/dieticians, Gut inflammation, Mucosal immunity, Immunopharmacology Group, Metagenomics, Food Scientist, food/gut microbiome specialist, Quality, Control Microbiologist, Group Manager, Food Protection & Probiotics, Microbiology Laboratory Technician, Microbiome disease, Bioinformatics, Microbiome scientists, Pediatrics, Microbiology Research Sites, Pathologists and Immunologists, Research Scientists Enquire Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/ ]]>
The human microbiome is the aggregate of all microbiotas that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Register Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/register Probiotics- Probiotics are live microorganisms promoted with claims that they provide health benefits when consumed, generally by improving or restoring the gut flora. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in your body. Bacteria is usually viewed in a negative light as something that makes you sick. However, you have two kinds of bacteria constantly in and on your body — good bacteria and bad bacteria. Probiotics are made up of good bacteria that helps keep your body healthy and working well. This good bacteria helps you in many ways, including fighting off bad bacteria when you have too much of it, helping you feel better. Key Highlights: • Effective Microbiome Therapeutics in Production • Role of human skin microbiome in precision health • The increasing pro bacterial beauty industry • Business collaborations- Regulations and Investments • Microbiome as a science and its clinical applications- skin, gut & women’s health • Regulatory pathways • Prebiotics, Probiotics and Postbiotics • R&D to commercialization- effectively translating research into commercialization • Rightly educating the consumer Academia- Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of: Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods, Nutritionists/dieticians, Gut inflammation, Mucosal immunity, Immunopharmacology Group, Metagenomics, Food Scientist, food/gut microbiome specialist, Quality, Control Microbiologist, Group Manager, Food Protection & Probiotics, Microbiology Laboratory Technician, Microbiome disease, Bioinformatics, Microbiome scientists, Pediatrics, Microbiology Research Sites, Pathologists and Immunologists, Research Scientists Enquire Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/ ]]> Wed, 24 Jan 2024 16:15:37 GMT /slideshow/2024-nextgen-microbiome-and-probiotics-conference-microbiology-microbiome-therapeutics-microbiome-gastroenterology-neonatology-functional-foods/265769261 9326389898@slideshare.net(9326389898) 2024 Next-Gen Microbiome and Probiotics Conference |Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods 9326389898 The human microbiome is the aggregate of all microbiotas that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Register Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/register Probiotics- Probiotics are live microorganisms promoted with claims that they provide health benefits when consumed, generally by improving or restoring the gut flora. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in your body. Bacteria is usually viewed in a negative light as something that makes you sick. However, you have two kinds of bacteria constantly in and on your body — good bacteria and bad bacteria. Probiotics are made up of good bacteria that helps keep your body healthy and working well. This good bacteria helps you in many ways, including fighting off bad bacteria when you have too much of it, helping you feel better. Key Highlights: • Effective Microbiome Therapeutics in Production • Role of human skin microbiome in precision health • The increasing pro bacterial beauty industry • Business collaborations- Regulations and Investments • Microbiome as a science and its clinical applications- skin, gut & women’s health • Regulatory pathways • Prebiotics, Probiotics and Postbiotics • R&D to commercialization- effectively translating research into commercialization • Rightly educating the consumer Academia- Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of: Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods, Nutritionists/dieticians, Gut inflammation, Mucosal immunity, Immunopharmacology Group, Metagenomics, Food Scientist, food/gut microbiome specialist, Quality, Control Microbiologist, Group Manager, Food Protection & Probiotics, Microbiology Laboratory Technician, Microbiome disease, Bioinformatics, Microbiome scientists, Pediatrics, Microbiology Research Sites, Pathologists and Immunologists, Research Scientists Enquire Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/ <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/next-genmicrobiomeandprobioticsconference-240124161537-7e93d39c-thumbnail.jpg?width=120&height=120&fit=bounds" /> The human microbiome is the aggregate of all microbiotas that reside on or within human tissues and biofluids along with the corresponding anatomical sites in which they reside, including the skin, mammary glands, placenta, seminal fluid, uterus, ovarian follicles, lung, saliva, oral mucosa, conjunctiva, biliary tract, and gastrointestinal tract. Types of human microbiota include bacteria, archaea, fungi, protists, and viruses. Register Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/register Probiotics- Probiotics are live microorganisms promoted with claims that they provide health benefits when consumed, generally by improving or restoring the gut flora. Probiotics are a combination of live beneficial bacteria and/or yeasts that naturally live in your body. Bacteria is usually viewed in a negative light as something that makes you sick. However, you have two kinds of bacteria constantly in and on your body — good bacteria and bad bacteria. Probiotics are made up of good bacteria that helps keep your body healthy and working well. This good bacteria helps you in many ways, including fighting off bad bacteria when you have too much of it, helping you feel better. Key Highlights: • Effective Microbiome Therapeutics in Production • Role of human skin microbiome in precision health • The increasing pro bacterial beauty industry • Business collaborations- Regulations and Investments • Microbiome as a science and its clinical applications- skin, gut & women’s health • Regulatory pathways • Prebiotics, Probiotics and Postbiotics • R&D to commercialization- effectively translating research into commercialization • Rightly educating the consumer Academia- Directors, Heads, Professors/Assistant Professors/ Associate Professor, Research Scholars, Scientists from the departments of: Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods, Nutritionists/dieticians, Gut inflammation, Mucosal immunity, Immunopharmacology Group, Metagenomics, Food Scientist, food/gut microbiome specialist, Quality, Control Microbiologist, Group Manager, Food Protection & Probiotics, Microbiology Laboratory Technician, Microbiome disease, Bioinformatics, Microbiome scientists, Pediatrics, Microbiology Research Sites, Pathologists and Immunologists, Research Scientists Enquire Now @ https://events.marketsandmarkets.com/microbiome-and-probiotics-conference/

2024 Next-Gen Microbiome and Probiotics Conference |Microbiology, Microbiome therapeutics, Microbiome, Gastroenterology, Neonatology, Functional foods from 9326389898

]]> 61 0 https://cdn.slidesharecdn.com/ss_thumbnails/next-genmicrobiomeandprobioticsconference-240124161537-7e93d39c-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post

http://activitystrea.ms/schema/1.0/posted

0 https://public.slidesharecdn.com/v2/images/profile-picture.png I am working as a Web Marketing Analyst and publishing reports on all platforms. https://cdn.slidesharecdn.com/ss_thumbnails/immunobioseries-240717085451-f4430dab-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/event-immunobio-series-14th-15th-october-2024-freiburg-germany/270292774 (Event) ImmunoBio Seri... https://cdn.slidesharecdn.com/ss_thumbnails/us-orphandrugsandrarediseasesconference-240620123347-fb9652b1-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/conference-orphan-drugs-and-rare-diseases-us-edition/269785759 (Conference) Orphan Dr... https://cdn.slidesharecdn.com/ss_thumbnails/probioticsppt-240614095854-fc1404e8-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/probiotics-conference-speakers-nigel-denby-zoe-marie-ellis-and-more-24th-25th-october-2024/269682720 Probiotics Conference ...